Astrovirus Replication Is Inhibited by Nitazoxanide In Vitro and In Vivo
Preprint
Abstract
Astroviruses (AstV) are a leading cause of diarrhea especially in the very young, the elderly, and immunocompromised populations. Despite their significant impact on public health, no drug therapies for astrovirus have been identified. In this study we fill this gap in knowledge and demonstrate that the FDA-approved broad-spectrum anti-infective drug nitazoxanide (NTZ) blocks astrovirus replication in vitro with a 50% effective concentration (EC 50 ) of approximately 1.47μM. It can be administered up to 8 hours post-infection and is effective against multiple human astrovirus serotypes including clinical isolates. Most importantly, NTZ reduces viral shed and clinical disease (diarrhea) in vivo , exhibiting its potential as a future clinical therapeutic. Importance: Human astroviruses (HAstV) are thought to cause between 2 and 9% of acute, non-bacterial diarrhea cases in children worldwide. HAstV infection can be especially problematic in immunocompromised people and infants where the virus has been associated with necrotizing enterocolitis, severe and persistent diarrhea, as well as systemic and often fatal disease. Yet no antivirals have been identified to treat astrovirus infection. Our study provides the first evidence that nitazoxanide may be an effective therapeutic strategy against astrovirus disease.Keywords
All Related Versions
- Published version: Journal of Virology, 94 (5).
This publication has 34 references indexed in Scilit:
- Norovirus gastroenteritis successfully treated with nitazoxanideJournal of Infection, 2011
- Serological Studies Confirm the Novel Astrovirus HMOAstV-C as a Highly Prevalent Human Infectious AgentPLOS ONE, 2011
- Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational LevelJournal of Biological Chemistry, 2009
- Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and RibavirinGastroenterology, 2009
- Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replicationAntiviral Research, 2008
- Antiparasitic Drug Nitazoxanide Inhibits the Pyruvate Oxidoreductases of Helicobacter pylori , Selected Anaerobic Bacteria and Parasites, and Campylobacter jejuniAntimicrobial Agents and Chemotherapy, 2007
- Nitazoxanide in the treatment of viral gastroenteritis: a randomized double‐blind placebo‐controlled clinical trialAlimentary Pharmacology & Therapeutics, 2006
- Astrovirus Induces Diarrhea in the Absence of Inflammation and Cell DeathJournal of Virology, 2003
- Persistent gastroenteritis in children infected with astrovirus: Association with serotype‐3 strainsJournal of Medical Virology, 2003
- Astrovirus infection in volunteersJournal of Medical Virology, 1979